1-3 of 3
Seth Steinberg, Ph.D.
Close
Sort by
Journal Articles

The Addition of Rituximab to Dose-Adjusted EPOCH with HAART Suspension Is Highly Effective and Tolerable in AIDS-Related Lymphoma (ARL) and Allows the Delivery of Abbreviated Chemotherapy.

Kieron Dunleavy, MD, Alan Wayne, M.D, Richard Little, M.D, Nicole Grant, M.P.H., Seth Steinberg, Ph.D, Elaine S. Jaffe, MD, Stefania Pittaluga, MD, Robert Yarchoan, MD, Jorge Carrasquillo, MD, John Janik, MD, Wyndham H. Wilson, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 930.
https://doi.org/10.1182/blood.V106.11.930.930
Published: 2005
Journal Articles

Abbreviated Treatment with Short-Course Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Is Highly Effective in AIDS-Related Lymphoma (ARL).

Kieron Dunleavy, M.D., Richard Little, M.D., Juan Gea-Banacloche, M.D., Nicole Grant, M.P.H., Seth Steinberg, Ph.D., Robert Yarchoan, M.D., Stefania Pittaluga, M.D., Elaine Jaffe, M.D., John Janik, M.D., Wyndham H. Wilson, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3111.
https://doi.org/10.1182/blood.V104.11.3111.3111
Published: 2004
Journal Articles

Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma.

Wyndham H. Wilson, M.D., Ph.D., Kieron Dunleavy, M.D., Stefania Pittaluga, M.D., Nicole Grant, M.P.H., Seth Steinberg, Ph.D., Mark Raffeld, M.D., Bruce Chabner, M.D., Michael Grossbard, M.D., Elaine Jaffe, M.D., Louis Staudt, M.D., Ph.D., John Janik, M.D.
Journal: Blood
Blood (2004) 104 (11): 159.
https://doi.org/10.1182/blood.V104.11.159.159
Published: 2004